Compare Flowserve Corporation Common Stock (FLS) vs Medline Inc. Class A Common Stock (MDLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Flowserve Corporation Common Stock vs Medline Inc. Class A Common Stock — how do they compare? Flowserve Corporation Common Stock trades at $70.6 (market cap $8.96B), while Medline Inc. Class A Common Stock trades at $35.75 (market cap $31.10B). The key difference: Medline Inc. Class A Common Stock is far larger — about 3.5× Flowserve Corporation Common Stock's market cap, and Flowserve Corporation Common Stock pays a 1.25% dividend while Medline Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Flowserve Corporation Common Stock for 0 Days and Medline Inc. Class A Common Stock for 0 Days on average.
| FLS | MDLN | |
|---|---|---|
Market Cap | $8.96B | $31.10B |
Volume | 1,946,178 | 4,471,639 |
Sector | Industrials | Health |
52-Week High | $92.04 | $49.99 |
52-Week Low | $49.09 | $31.64 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.55B | $41.07B |
Dividend Yield | 1.25% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Flowserve Corporation Common Stock
Flowserve Corporation is a Texas-based manufacturer of engineered flow-control equipment, producing industrial pumps, mechanical seals, valves, and automation products through its Flowserve Pumps Division and Flow Control Division, serving the oil and gas, chemical, power, and water industries in more than 50 countries.
Read more on FLS →About Medline Inc. Class A Common Stock
Medline provides medical-surgical products and supply-chain solutions for healthcare providers. Its portfolio and distribution network serve hospitals, clinics, long-term care facilities, and other care settings.
Read more on MDLN →
